Heather J. Finlay

1.5k total citations
36 papers, 1.2k citations indexed

About

Heather J. Finlay is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Heather J. Finlay has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Organic Chemistry. Recurrent topics in Heather J. Finlay's work include Cardiac electrophysiology and arrhythmias (11 papers), Ion channel regulation and function (8 papers) and Natural product bioactivities and synthesis (7 papers). Heather J. Finlay is often cited by papers focused on Cardiac electrophysiology and arrhythmias (11 papers), Ion channel regulation and function (8 papers) and Natural product bioactivities and synthesis (7 papers). Heather J. Finlay collaborates with scholars based in United States, Canada and Germany. Heather J. Finlay's co-authors include Tadashi Honda, Gordon W. Gribble, Michael B. Sporn, Nanjoo Suh, Frank G. Favaloro, Lothar Bore, Yongping Wang, Nicole Benoit, Charlotte R. Williams and George M. Strunz and has published in prestigious journals such as Circulation, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Heather J. Finlay

34 papers receiving 1.1k citations

Peers

Heather J. Finlay

PHARM

TOXIC

Denyse Bagrel France

Sixun Peng China

Victor Kenyon United States

Wenying Ren United States

Barbara De Filippis Italy

Mei‐Ing Chung Taiwan

Jiyan Pang China

Noboru Shoji Japan

Li‐Jiang Xuan China

Lingjuan Zhu China

Denyse Bagrel France

Heather J. Finlay

546 ×0.8

433 ×1.4

161 ×1.0

PHARM

91 ×0.6

PHARM

102 ×0.8

TOXIC

Citations per year, relative to Heather J. Finlay Heather J. Finlay (= 1×) peers Denyse Bagrel

Countries citing papers authored by Heather J. Finlay

Since Specialization

Citations

This map shows the geographic impact of Heather J. Finlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather J. Finlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather J. Finlay more than expected).

Fields of papers citing papers by Heather J. Finlay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather J. Finlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather J. Finlay. The network helps show where Heather J. Finlay may publish in the future.

Co-authorship network of co-authors of Heather J. Finlay

This figure shows the co-authorship network connecting the top 25 collaborators of Heather J. Finlay. A scholar is included among the top collaborators of Heather J. Finlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather J. Finlay. Heather J. Finlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meng, Wei, Zulan Pi, Karen A. Rossi, et al.. (2021). Identification of a Hydroxypyrimidinone Compound (21) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure. Journal of Medicinal Chemistry. 64(24). 18102–18113. 7 indexed citations

Ji, Jiang, Jeffrey S. Bostwick, Peter S. Gargalovic, et al.. (2021). Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists. Bioorganic & Medicinal Chemistry Letters. 50. 128325–128325. 6 indexed citations

Johnson, James A., Soong‐Hoon Kim, Jiang Ji, et al.. (2021). Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate. Journal of Medicinal Chemistry. 64(6). 3086–3099. 14 indexed citations

Meng, Wei, Leonard P. Adam, Kamelia Behnia, et al.. (2019). Benzothiazole-based compounds as potent endothelial lipase inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(20). 126673–126673. 4 indexed citations

Wang, Tammy C., Jennifer X. Qiao, David S. Taylor, et al.. (2018). Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3721–3725. 7 indexed citations

Chen, Xueqing, Christine Huang, Ming Chang, et al.. (2018). Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical Species. Journal of Pharmaceutical Sciences. 107(5). 1352–1360. 14 indexed citations

Finlay, Heather J., James A. Johnson, John Lloyd, et al.. (2016). Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a PotentI_KurInhibitor. ACS Medicinal Chemistry Letters. 7(9). 831–834. 11 indexed citations

Jiang, Ji, Heather J. Finlay, James A. Johnson, et al.. (2016). Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(14). 3278–3281. 1 indexed citations

Lloyd, John, Heather J. Finlay, James A. Johnson, et al.. (2015). Pseudosaccharin amines as potent and selective KV1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 25(21). 4983–4986. 5 indexed citations

10.

Wang, Yufeng, Heather J. Finlay, Lalgudi S. Harikrishnan, et al.. (2014). Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(3). 860–864. 5 indexed citations

11.

Johnson, James A., Ningning Xu, Yoon Jeon, et al.. (2014). Design, synthesis and evaluation of phenethylaminoheterocycles as Kv1.5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(14). 3018–3022. 5 indexed citations

12.

Finlay, Heather J., Ji Jiang, Mary Lee Conder, et al.. (2013). Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 23(6). 1743–1747. 9 indexed citations

13.

Harikrishnan, Lalgudi S., Heather J. Finlay, Jennifer X. Qiao, et al.. (2012). Synthesis of tertiary carbinamines. Tetrahedron. 68(12). 2696–2703. 11 indexed citations

14.

Lloyd, John, Heather J. Finlay, Lin Yan, et al.. (2010). Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 20(4). 1436–1439. 81 indexed citations

15.

Sun, Huabin, et al.. (2009). Abstract 2515: A Selective IKur Blocker, BMS-394136 Selectively Prolongs Atrial APD and Refractoriness in Beagles and Rabbits. Circulation. 120. 1 indexed citations

16.

Lloyd, John, Heather J. Finlay, Karnail S. Atwal, et al.. (2009). Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 19(18). 5469–5473. 35 indexed citations

17.

Vaccaro, Wayne, Tram Huynh, John Lloyd, et al.. (2008). Dihydropyrazolopyrimidine Inhibitors of KV1.5 (IKur). Bioorganic & Medicinal Chemistry Letters. 18(24). 6381–6385. 24 indexed citations

18.

Finlay, Heather J., et al.. (2008). Pyrano-[2,3b]-pyridines as potassium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 18(8). 2714–2718. 14 indexed citations

19.

Lloyd, John, Karnail S. Atwal, Heather J. Finlay, et al.. (2007). Benzopyran sulfonamides as KV1.5 potassium channel blockers. Bioorganic & Medicinal Chemistry Letters. 17(12). 3271–3275. 27 indexed citations

20.

Dumas, Michael, et al.. (1996). In vitro interactions betweenCylindrocladium floridanum and species of Trichoderma. Canadian Journal of Plant Pathology. 18(4). 325–329. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact